<DOC>
	<DOCNO>NCT02590900</DOCNO>
	<brief_summary>Compared early postpartum ( 10-15 week ) observation , paracetamol clearance significantly high ( 21.1 vs 11.7 l.h-1 , + 80 % ) delivery . This high clearance due disproportional increase glucuronidation ( 11.6 vs 4.76 l.h-1 , + 144 % ) , proportional increase oxidation clearance ( 4.95 vs 2.77 l.h-1 , 78 % ) primary renal clearance ( 1.15 vs 0.75 l.h-1 , 53 % ) [ KUlo et al , Int J Obstet Anesth ] . This increase glucuronidation clearance may part drive oestradiol , may explain within individual difference paracetamol metabolism ( e.g . oral contraceptive , follicular v luteal phase , postpartum , pregnancy , duration pregnancy ) young woman . Based pooled analysis , investigator aim explore impact covariates paracetamol metabolism base plasma urine collection woman delivery , postpartum ( early , late ) healthy volunteer , either oral contraceptive ( OC ) follow intravenous ( iv ) paracetamol administration .</brief_summary>
	<brief_title>Disposition Intravenous Paracetamol Young Women</brief_title>
	<detailed_description>This study aim perform pooled analysis : 1 . Paracetamol PK data recently publish 47 pregnant woman . In case , iv paracetamol administer q6h delivery ( caesarean ) 24 h. 8 recruit second time additional single dose pK study postpartum ( Kulo et al , Br J Clin Pharmacol 2013 ) . 2 . The PK data initially publish Gregoire et al , limited female volunteer , oral contraceptive ( n=14 ) ( Gregoire et al , Clin Pharm Ther 2007 ) 3 . A dataset 8 young woman oral contraceptive , iv paracetamol , single dose .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1. informed consent 2. patient ( pregnant woman delivery ) , clinical indication ( post caesarean analgesia , NPO ) administer iv paracetamol . 1. intolerance paracetamol 2. withdrawal inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>pregnancy</keyword>
	<keyword>oral contraceptive</keyword>
	<keyword>oestradiol</keyword>
</DOC>